If you have glass slides or a tissue block—or they are still held by the original laboratory—TrueDx can explain the available scanning and transfer pathways before specialist review.
The appropriate option depends on specimen type, location, custody requirements, scanner availability, and the originating laboratory's release process.
When an approved scanning location is available, slides can be directed there for whole-slide imaging and image quality review.
When local scanning is not available, eligible material may be sent using the approved packaging, courier, and chain-of-custody instructions.
After scanning and quality control, the Path23 workflow routes the case to an eligible subspecialty pathologist. The resulting report can include annotated representative images, measurements, visual maps, and structured findings when clinically appropriate.
Do not mail slides or blocks until TrueDx or the participating organization confirms that the case is accepted and provides the correct receiving, packaging, tracking, authorization, and return instructions.
The Path23-assisted report can give the reviewing pathologist additional visual and quantitative information from the digital slide. When appropriate, the signed consultation may include annotated tissue regions, cellular measurements, heatmaps, and representative microscopic fields.
AI-generated information supports the pathologist’s review. It is not an independent diagnosis and does not replace discussion with your treating clinician.
Name and location of the facility currently holding the slides or block.
Whether you have a report, glass slides, paraffin block, or existing digital images.
The treating clinician who should receive and discuss the consultation report.
Ask for secure intake instructions and tell us only whether the material is digital, glass slides, a block, or still at the original laboratory.
Do not submit patient information. TrueDx is not an emergency service. Discuss treatment decisions with your treating clinician.